Skip to main content
. Author manuscript; available in PMC: 2016 Sep 16.
Published in final edited form as: Pediatr Res. 2016 Mar 16;80(1):101–109. doi: 10.1038/pr.2016.50

TABLE 2.

LIST OF ANTAGONISTS AND INHIBITORS

Antagonist Synonym Dose (s) Target
Caffeine 1,3,7-Trimethylxanthine 50, 100, 200 µM A1 > A2 > A3
DPCPX 1,3-Dipropyl-8cyclopentylxanthine 10 nM A1
MRS1220 9-Chloro-2-(2-furanyl)-5-(phenylacetyl amino)-[1,2,4]triazolo[1,5-c] quinazoline 10 nM A3
RO-201724 4- (3- Butoxy- 4- methoxybenzyl)- 2- imidazolidinone 10 µM PDE IV
RP-cAMPs Rp-Adenosine 3′,5′-cyclic monophosphorothioate triethylammonium salt hydrate 50 µM cAMP-PKA

A1, A2a, A2b, A3, adenosine receptor subtypes; cAMP, cyclic adenosine monophosphate; PDE, phosphodiesterase; PKA, protein kinase A